ARCHIVES

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

This article is from The Cancer Letter archive.

Vol. 20 No. 46 | December 2, 1994

Download PDF Visit The Full Archive

Related Articles

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Gleevec Approved For Pediatric CML

May 23, 2003

SEER Program Challenged, Will Face Review

May 9, 1980

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006